Descrizione del progetto
Un punteggio di rischio basato sull’IA per il carcinoma gastrico
L’intelligenza artificiale (IA) si sta progressivamente inserendo nell’assistenza sanitaria per migliorare la valutazione dei rischi di malattia e prevedere gli esiti clinici o terapeutici. Il progetto AIDA, finanziato dall’UE, intende creare un punteggio di rischio basato sull’IA per il carcinoma gastrico, una malattia solitamente individuata a uno stadio avanzato quando si può fare poco in termini di trattamento. Un gruppo di ricerca combinerà i dati provenienti da diverse fonti per rilevare l’infiammazione gastrica pretumorale e produrre un punteggio di rischio per il carcinoma gastrico. L’approccio chiarirà come l’infiammazione gastrica si evolve in un tumore e aiuterà il personale medico a formulare un piano di trattamento personalizzato per prevenire questo tipo di carcinoma.
Obiettivo
Most cases of gastric cancer (GC) are detected at a late stage, when patients have a median life expectancy of about a year. Diagnosing people at risk of developing GC at the pre-symptomatic stage, typically chronic gastric inflammation, could significantly improve the outlook.
Artificial intelligence (AI) can help clinicians make sense of their own data by automating much of the treatment and analysis, which require manual work and years of experience. But it can do more: it can bring together available data from various sources into a vast data lake and cross-correlate the data to derive a ‘risk score’ for gastric cancer and shed light on the mechanisms of its evolution.
Aida aims to do just that. It helps researchers understand the mechanisms that trigger gastric oncogenesis, helps clinicians diagnose precancerous inflammation at the earliest possible stage, suggests personalised therapeutic strategies for treatment and follow-up, and makes personalised recommendations for monitoring patient health status, thus contributing to gastric cancer prevention.
This places Aida squarely on Europe’s agenda of ‘Staying healthy in a rapidly changing society’. Aida unites some of Europe’s leading authorities in the field of gastric inflammation, gastric cancer, leading AI and machine learning experts, experts on data governance and privacy, representatives of the public administration and patient advocates. Aida also has strong ties with the industry.
After the project, the results will live on in a foundation that acts as a transnational focal point for chronic gastric inflammation — and GC in general. We hope that the solid, inclusive design principles of Aida, its societal relevance and its durability will spawn a vigorous ecosystem around chronic gastric inflammation, its understanding and its treatment. And we hope that it will inspire other data collaboratives in health — for other chronic inflammations, other forms of cancer or other ailments altogether.
Campo scientifico
Parole chiave
Programma(i)
Argomento(i)
Meccanismo di finanziamento
HORIZON-RIA - HORIZON Research and Innovation ActionsCoordinatore
46010 Valencia
Spagna